Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Life Insurance

CNO Reports Higher Annuity Sales

X
Your article was successfully shared with the contacts you provided.

CNO Financial Services Group Inc. is reporting higher annuity sales, but lower Medicare supplement and long-term care insurance sales, for the second quarter.

(Related: Annuity Players Continue to Fight Low Rates)

The Carmel, Indiana-based company posted the following first-year collected premium results for its Bankers Life unit:

  • Annuities: Sales increased to $262 million, from $205 million.

  • Medicare supplement insurance: Sales fell to $18 million, from $19 million.

  • Long-term care insurance: Sales fell to $4.1 million, from $4.4 million.

New annualized premium from life insurance sales was soft at all three of CNO’s major divisions.

Sales fell 16% at Bankers Life, to $18 million; 5.6% at Washington National, to $1.7 million; and 16% at the Colonial Penn direct sales unit, to $16 million.

The average number of agents with three or more years experience held steady at about 1,900 at Bankers Life and about 300 at Washington National.

CNO as a whole is reporting $83 million in net income for the second quarter on $1.1 billion in revenue, compared with $60 million in net income on $1 billion in revenue for the second quarter of 2016. 

The company’s averge rate on newly invested money fell to 4.64% from 5.5%, but the overall earned yield increased to 5.54%, from 5.52%. The new money rate fell partly because efforts to minimize cash float.

Earnings on alternative investments increased to $6.1 million, from $4.6 million.

— Read 5 Trump-Era Health Policy Losers, and 5 Possible Winners on ThinkAdvisor


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.